Redbiotec has negotiated an exclusive license deal with the ETH Zürich over patented MultiBac technology and the ETH has now become a partner and shareholde of Redbiotec.
Redbiotec has negotiated an exclusive license deal with the ETH Zürich over patented MultiBac technology and the ETH has now become a partner and shareholde of Redbiotec.